Showing of 1-10 from 1927 result
November 16, 2018, Friday | Companies
Shares of Dr.Redyy's closed at Rs 2,470.85 a unit, up by 0.36 per cent compared to the previous close, at BSE on Friday
November 16, 2018, Friday | Companies
The approval from the US FDA is for Abacavir and Lamivudine tablets USP in the strength of 600 mg/300 mg, Zydus Cadila said
November 16, 2018, Friday | Companies
The approved product is generic version of Sanofi-Aventis US' Aubagio
November 14, 2018, Wednesday | Companies
Analysts cut earnings estimates on muted India business growth outlook, rising expenses on specialty launches in the US
November 07, 2018, Wednesday | Companies
Insulin Glargine is the first biosimilar from India to be approved and launched in Japan
October 28, 2018, Sunday | Companies
For Q2, DRL's net profit at Rs 5.04 billion, up 77 per cent year-on-year
October 20, 2018, Saturday | Companies
The drug will be available in three doses of 100 mg, 300 mg, and 400 mg
October 19, 2018, Friday | Technology
The FDA has been doing away with regulatory action altogether on many diagnostic health apps targeting consumers
October 12, 2018, Friday | Companies
Zydus Cadila said the drug will be produced at the group's formulations manufacturing facility at SEZ, Ahmedabad
October 09, 2018, Tuesday | Companies
Alkem Labs, Glenmark Pharmaceuticals and Impax Labs were also granted product approval to manufacture and market Colesevelam HCl tablets by the US drug regulator
October 08, 2018, Monday | Companies
Axio Biosolutions, backed by Accel, IDG and Ratan Tata's UC-RNT, is set to disrupt the market for gauze and surgical tapes with a novel polymer-based product
October 05, 2018, Friday | Companies
Zydus Cadila has more than 220 approvals and so far
October 01, 2018, Monday | Companies
Gleevec and its generic equivalents saw sales of approximately $868 mn in the US for the last twelve months ending in July 2018
September 19, 2018, Wednesday | Opinion
The FDA Bhawan in Delhi seems to have shed its anti-foreign stand of three years ago. Will the soft touch work?
September 15, 2018, Saturday | Companies
Ajovy injection seen generating $500 million in sales by 2022
September 07, 2018, Friday | Companies
Shares of Sun Pharmaceutical Industries on Friday closed at Rs 664.20 per scrip on BSE, down 1.84 per cent from its close
September 05, 2018, Wednesday | Companies
The tablets, used to treat hypokalemia, will be available in 600 mg and 750 mg dosage
August 25, 2018, Saturday | Companies
Experts claim law does not make compensation compulsory
August 24, 2018, Friday | PTI Stories
Shares of Lupin were today trading at Rs 903 per scrip on BSE, down 0.07 per cent from its previous close
